Article thumbnail
Location of Repository

Competitive Binding of Somatomedin to the Insulin Receptors of Adipocytes, Chondrocytes, and Liver Membranes

By Raymond L. Hintz, David R. Clemmons, Louis E. Underwood and Judson J. Van Wyk


The action of growth hormone on skeletal tissue is mediated through somatomedin, a low molecular weight peptide found in serum. This peptide, formerly known as “sulfation factor” or “thymidine factor,” produces marked insulin-like effects in various target tissues. Since at least some of the metabolic effects of insulin on target cells are initiated by a highly specific interaction with receptors on cell membranes, this study was undertaken to determine whether somatomedin might interact with the same binding sites. It was found that somatomedin, at physiological concentrations, competes with (125)I-labeled insulin for receptor sites on isolated fat cells, liver membranes, and isolated chondrocytes, and that the relative binding affinities of insulin and somatomedin reflect the in vitro biological potencies of the two hormones in these tissues. This is the first demonstration of a peptide other than insulin, proinsulin, or derivatives of insulin competing for insulin-binding sites, and implies a structural, as well as a functional, homology between somatomedin and insulin. Somatomedin may be only one of a larger group of homologous pleiotypic peptides with different target organ specificities

Topics: Biological Sciences: Biochemistry
Year: 1972
DOI identifier: 10.1073/pnas.69.8.2351
OAI identifier:
Provided by: PubMed Central
Sorry, our data provider has not provided any external links therefore we are unable to provide a link to the full text.

Suggested articles

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.